Details: human insulin analogue rapid acting inj and 100 iu or ml recombinant dna origin 300 iu disposable pen with 5 needles per pen , insulin highly purified isophane human nph 40 iu or ml and 10 ml inj , biphasic isophane insulin 50 percent soluble insuline and 50 percent isophan insulin item category/ suspension and 100 iu or ml of 3 ml cartridge , soluble insulin injection 100 iu or ml human actrapid of 3 ml pen , insulin isophane or nph 70 percent and human insulin or soluble insulin 30 percent mixtard 30 or 70 insulin inj 100 iu or ml and 3 ml pen , erythropoeitin human recombinant 2000 iu human insulin analogue rapid acting inj, 100 iu / ml (recombinant dna origin) 300 iu disposable pen with 5 needles per pen, insulin highly purified isophane (human nph) 40 iu/ml, 10 ml inj, biphasic isophane insulin (50%
Sector: Defense